Buscar resultados de ensayos clínicos
Angioimmunoblastic Lymphadenopathy With Dysproteinemia - 244 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: A Phase II Study of Rituximab Combined With CHOP in T-cell Angio-immunoblastic Lymphoma Condición: Untreated T-cell Angioimmunoblastic Lymphoma Fecha: 2005-09-12 Intervenciones:
|
Completed |
Nombre del estudio: Fludarabine, Cyclophosphamide, and Thalidomide in Treating Patients With Angioimmunoblastic T-Cell Lymphoma Condición: Lymphoma Fecha: 2009-08-12 Intervenciones:
|
Terminated |
Nombre del estudio: Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell Lymphoma Condición: Lymphoma Fecha: 2003-10-03 Intervenciones: Drug: cyclosporine Cyclosporine doses will be based on actual body weight unless actual body weight is & |
Recruiting |
Nombre del estudio: Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma Condición:
|
Completed |
Nombre del estudio: Study of Orally Administered AG-221 in Subjects With Advanced Solid Tumors, Including Glioma, and With Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation Subjects With Advanced Solid Tumors, Including Glioma, and With Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation Condición:
|
Recruiting |
Nombre del estudio: A Study of Plitidepsin in Patients With Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma Condición: Lymphoma Fecha: 2017-01-16 Intervenciones: Drug: plitidepsin Other Name: APLD Aplidine |
Recruiting |
Nombre del estudio: Efficacy of a Treatment With CHOP and Lenalidomide in First Line in Angioimmunoblastic T-cell Lymphoma (AITL) Condición: T-cell Lymphoma Fecha: 2012-01-20 Intervenciones: Drug: Lenalidomide Lenalidomide |
Recruiting |
Nombre del estudio: Risk Stratification of Nodal PTCL Condición:
|
Recruiting |
Nombre del estudio: Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP Condición:
|
Recruiting |
Nombre del estudio: CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study Condición:
|